Vinati Organics Ltd. Share Price

Overview

Vinati Organics Ltd. share price is currently ₹1,142.51, down by - ₹15.38 (1.33%) from its previous closing price of ₹1,157.89. The share price has gained 5.47% over the past month and declined -30.48% over the past year. The stock's 52-week low and high are ₹940.37 and ₹1,614.58, respectively. Vinati Organics Ltd. has a market capitalisation of ₹ 11,937.62 Cr. The share price was last updated on 20 Nov 2026, 03:29 PM IST.

Vinati Organics Ltd.
Vinati Organics Ltd.
VINATIORGA
 ₹0.00
- ₹15.38
1.33%
Chemicals
 ₹0.00(%)1D

Updated: 20 Nov 2026, 03:29:53 pm IST

Market Data

Open Price

 ₹1,143.63

Prev. Close

 ₹1,157.89
 ₹1,131.42

Day Low

 ₹1,153.11

Day High

 ₹940.37

52 Week Low

 ₹1,614.58

52 Week High

ChemicalsChemicals
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

28.76

Sector PE

29.58

PB Ratio

3.75

Sector PB

4.13

EPS

39.72

Dividend Yield

0.64

Today's Volume

31.702 K

5 Day Avg. Volume

54.873 K

PEG Ratio

3.03

Market Cap.

₹ 11,937.62 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 850% at ₹8.5/Share
16-Sep-202616-Sep-2026
DividendsFinal Dividend of 750% at ₹7.5/Share
19-Sep-202519-Sep-2025
DividendsFinal Dividend of 700% at ₹7/Share
03-Sep-202404-Sep-2024

Mutual Fund Ownership

Mutual Fund Holder
Sep 26
Shares held
Oct 26
Shares held
Aditya Birla Sun Life Flexi Cap Fund - Regular Plan - Growth14.49 Lac
14.49 Lac
no change
Nippon India Small Cap Fund - Growth12.44 Lac
12.44 Lac
no change
Canara Robeco Large and Mid Cap Fund - Regular Plan - Growth11.44 Lac
11.44 Lac
no change
ICICI Prudential Multi Asset Allocation Fund - Growth10.69 Lac
10.69 Lac
no change
Aditya Birla Sun Life ELSS Tax Saver Fund - IDCW7.75 Lac
7.75 Lac
no change

About Vinati Organics Ltd. 👋

Vinati Organics Limited is an India-based company, which is primarily engaged in the business of manufacturing of specialty chemical and organic intermediaries. Its products include Specialty Aromatics, Specialty Monomers, Butyl Phenols, Antioxidants, Other Specialty Products, Miscellaneous Polymer, Inorganic Chemicals. Its Specialty Aromatics include Iso Butyl Benzene (IBB); N-Butyl Benzene or NBB; Secondary Butyl Benzene (SBB); Tertiary Amyl Benzene; 3-Phenylpentane; the C10 Aromatic solvent and 4-Butylaniline. Its specialty monomers include 2-Acrylamido 2-Methyl Propane Sulphonic Acid (ATBS); Sodium Salt Of 2-Acrylamido-2-Methylpropane Sulphonic Acid (NAATBS); N-Tertiary Butyl Acrylamide (TBA) and N-Tertiary Octyl Acrylamide (TOA). Butyl Phenols available at Vinati Organics are a class of different compounds that are manufactured by the reaction of phenols with isobutylene. Its diverse range of antioxidants under the trade name of VEENOX.

Analyst Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
CA Sumit Mangla

CA Sumit Mangla

11 Nov • 2:55 PM · SEBI-Registered Analyst

Anupam Rasayan guides FY27 revenue at ₹4,800–5,000 Cr

ANURAS Anupam Rasayan India Limited (ANURAS) has guided for FY27 consolidated revenue of ₹4,800–5,000 Cr. EBITDA margin guidance is at 23%, with H2 FY27 expected to be very strong Management indicated that consolidation of recent acquisitions has been completed. H2 FY27 is expected to deliver ₹2,400–2,500 Cr in revenue, supported by full contribution from acquired businesses and new contracts. The company anticipates organic growth of 20–25% over the medium term, with acquisition synergies and improved product mix supporting margins. The key triggers are the FY27 revenue guidance of ₹4,800–5,000 Cr and the expectation of a strong H2, backed by completed acquisition consolidation. This supports the company’s specialty chemicals and pharma expansion strategy. Peers such as Aarti Industries, Navin Fluorine and Vinati Organics may face comparison on growth outlook and margin trajectory. Near-term prices could react positively to the strong revenue guidance and H2 visibility. Risks include slower-than-expected contribution from acquisitions, demand softness in end markets, or margin pressure from input costs. Competitors listed: Aarti Industries, Navin Fluorine, Vinati Organics. We have no financial interest in this news.

See More
Pyrifera Investment Advisors

Pyrifera Investment Advisors

9 Nov • 9:58 PM · SEBI-Registered Analyst

Vinati organics plans 500 crore specialty chemical capex

Vinati Organics announced a ₹500 crore capital expenditure plan to develop new specialty chemicals for fragrances, personal care, and water treatment. The company is also exploring an additional ₹500 crore expansion pending land acquisition. The ₹500 crore capex will be funded entirely through internal accruals and commercialized within two years. This matters because it diversifies the company's revenue beyond its core ATBS and Butyl Phenol segments into higher-margin specialty applications. I am watching the Q3 FY27 earnings call in January 2027 for updates on the land acquisition timeline for the secondary ₹500 crore project and the sequential volume recovery metrics in the ATBS segment. The market currently prices Vinati Organics purely on its legacy ATBS volume cycles, viewing new capex as a distant, margin-dilutive distraction. What the consensus misses is the structural operating leverage this specific expansion enables. Step one: funding entirely through internal accruals proves robust cash generation without balance sheet debt drag. Step two: targeting fragrances and water treatment leverages existing chemical competencies, minimizing R&D failure risk. Step three: the projected 24%-25% EBITDA margin for FY27, despite input cost pressures, demonstrates exceptional pricing power that will only amplify as the new ₹100 crore MEHQ and BHA revenue streams scale. The market misprices this as routine capacity addition, ignoring the compounding return on capital employed (ROCE) from a highly integrated, debt-free specialty chemical platform. Accumulate for long-term specialty chemical margin expansion. Disclosure: I do not hold positions in this stock. This is for educational purposes only and does not constitute investment advice. VINATIORGA

See More
Neha Gupta

Neha Gupta

24 Aug • 10:24 AM · SEBI-Registered Analyst

🔥 14 BEST NICHE STOCKS WITH STRONG MOATS

🔥 14 BEST NICHE STOCKS WITH STRONG MOATS Not every great business needs to be a giant. Some of the best wealth creators operate in niche industries with high entry barriers, strong capabilities and limited competition. Here are 14 interesting niche businesses to track 👇 1. CDSL — Depository CDSL 2. MCX — Commodity Exchange 3. CAMS — Mutual Fund RTA 4. Astra Microwave — RF & Microwave Systems 5. Solar Industries — Explosives & Defence 6. TAAL Enterprises — Aerospace Structures 7. Zen Technologies — Anti-Drone & Defence Systems 8. Neuland Labs — Complex Pharmaceuticals 9. Shilchar Technologies — Specialized Transformers 10. Data Patterns — Defence Electronics 11. Garware Technical Fibres — High-Performance Technical Textiles 12. Wendt India — Superabrasives 13. Poly Medicure — Medical Devices 14. Vinati Organics — Specialty Chemicals 🎯 The common thread: Niche market + specialized capabilities + entry barriers = potential long-term moat. Keep them on your watchlist and track how the business evolves. 📈

See More
CA Sumit Mangla

CA Sumit Mangla

14 Aug • 8:56 PM · SEBI-Registered Analyst

Anupam Rasayan Q1 Net Profit Rises 14% to ₹38.7 Cr; EBITDA Up 31% YoY

ANURAS India reported consolidated net profit of ₹387 million for Q1, up from ₹340 million year-on-year. EBITDA rose to ₹1.62 billion from ₹1.24 billion, a 31% increase, while EBITDA margin moderated slightly to 24.8% from 25.6%. The results reflect continued growth in the specialty chemicals and custom synthesis business amid a strong operational performance. Top stocks in the specialty chemicals industry: Vinati Organics, Aarti Industries, and Navin Fluorine International.

See More
Dhwani Patel

Dhwani Patel

8 Aug • 10:07 PM · SEBI-Registered Analyst

VINATIORGA - Bulls to turns to bears

VINATIORGA Vinati Organics appears to be transitioning from a prolonged corrective phase into a broad sideways consolidation, with price oscillating between long-term support and resistance. The narrowing price structure suggests selling pressure is easing, while the sideways movement indicates a balance between buyers and sellers. Immediate support lies near the rising trendline, with the falling trendline acting as the key resistance. A decisive breakout from this long-term range is likely to determine the stock's next major trend.

See More
CA Sumit Mangla

CA Sumit Mangla

30 Jul • 1:26 PM · SEBI-Registered Analyst

Vinati Organics Expects Around 15% Volume Growth in FY27

VINATIORGA has indicated that volume growth should be around 15% in FY27. The guidance is supported by an expected recovery in demand for key products such as ATBS, along with continued momentum in the antioxidants segment and contributions from capacity expansions. Management anticipates stronger volumes in ATBS (around 15-20%) and steady performance in other products. The company is also looking at EBITDA margins in the 26-27% range. Revenue contribution from its subsidiary is expected to begin from October 2026, providing additional support to overall growth.

See More

News & Events

Frequently Asked Questions

What is the share price of Vinati Organics Ltd.?

What is the market cap of Vinati Organics Ltd.?

Should I buy Vinati Organics Ltd. stock now?

What is the 52 week high and low of Vinati Organics Ltd.?

Is the Vinati Organics Ltd. stock good to buy?

Is Vinati Organics Ltd. a good buy for the long term?

Is Vinati Organics Ltd. overvalued or undervalued?

What is the PE and PB ratio of Vinati Organics Ltd.?

Start Now